A detailed history of Everhart Financial Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Everhart Financial Group, Inc. holds 10,101 shares of ABT stock, worth $1.19 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
10,101
Previous 9,020 11.98%
Holding current value
$1.19 Million
Previous $937,000 22.84%
% of portfolio
0.26%
Previous 0.25%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $108,175 - $127,698
1,081 Added 11.98%
10,101 $1.15 Million
Q2 2024

Jul 24, 2024

BUY
$100.73 - $112.44 $61,445 - $68,588
610 Added 7.25%
9,020 $937,000
Q1 2024

May 13, 2024

BUY
$109.52 - $120.96 $339,402 - $374,855
3,099 Added 58.35%
8,410 $955,000
Q4 2023

Jan 12, 2024

SELL
$90.19 - $110.4 $19,751 - $24,177
-219 Reduced 3.96%
5,311 $584,000
Q3 2023

Oct 25, 2023

SELL
$95.53 - $114.62 $10,699 - $12,837
-112 Reduced 1.99%
5,530 $535,000
Q2 2023

Jul 13, 2023

BUY
$100.78 - $112.29 $66,917 - $74,560
664 Added 13.34%
5,642 $615,000
Q1 2023

Apr 25, 2023

SELL
$96.86 - $114.01 $46,008 - $54,154
-475 Reduced 8.71%
4,978 $504,000
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $127,855 - $149,994
1,345 Added 32.74%
5,453 $598,000
Q3 2022

Oct 12, 2022

BUY
$96.76 - $112.03 $3,773 - $4,369
39 Added 0.96%
4,108 $398,000
Q2 2022

Jul 12, 2022

SELL
$102.07 - $123.37 $13,779 - $16,654
-135 Reduced 3.21%
4,069 $442,000
Q1 2022

Apr 18, 2022

BUY
$114.02 - $139.04 $122,571 - $149,468
1,075 Added 34.36%
4,204 $498,000
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $76,827 - $94,070
665 Added 26.99%
3,129 $440,000
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $287,450 - $318,003
2,464 New
2,464 $291,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Everhart Financial Group, Inc. Portfolio

Follow Everhart Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everhart Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Everhart Financial Group, Inc. with notifications on news.